Management of Small Gallbladder Polyps and Associated Conditions

Gallbladder Polyp Management

The American College of Radiology and European multisociety guidelines agree that polyps ≤6 mm without risk factors should not be followed 1
Polyps ≤5 mm require no follow-up whatsoever when you have no risk factors for malignancy, with studies documenting 0% malignancy rate in polyps smaller than 5 mm 1, 2
Risk factors that would change management include Asian ethnicity 1, sessile morphology (broad-based rather than pedunculated) 3, and focal gallbladder wall thickening >4 mm adjacent to the polyp 1
If you had any of these risk factors with your 5 mm polyp, then surveillance ultrasound would be recommended at 6 months, 1 year, and 2 years 1
Future imaging would only be warranted if you develop symptoms potentially attributable to the gallbladder (right upper quadrant pain, biliary colic) 4, or the polyp grows to ≥10 mm on any future imaging done for other reasons 1

Stable simple hepatic cysts require no follow-up imaging regardless of size 4
Simple hepatic cysts are benign lesions that typically follow an indolent course without significant changes over time 4
Post-treatment imaging is not indicated even if cysts were treated, as success is defined by symptom relief, not volume reduction 4
Ultrasound should be performed only if you develop signs of complications (fever suggesting infection, acute pain suggesting hemorrhage) 4

Stable simple renal cysts require no routine follow-up based on standard nephrology practice 4
Both cortical and parapelvic cysts are typically benign findings that remain stable over time 4
No specific surveillance protocol is needed for simple renal cysts unless they become symptomatic or demonstrate concerning features on initial imaging 4

For suspected mild fatty infiltration, address metabolic risk factors including weight management, diabetes control, and lipid management 1
No specific imaging follow-up is required for mild fatty liver alone 4
Routine monitoring through clinical assessment and laboratory tests (liver enzymes, metabolic panel) is sufficient 4

Do not order routine surveillance ultrasound for your 5 mm polyp, as this represents overdiagnosis and unnecessary healthcare utilization 1, 3
Do not confuse tumefactive sludge with true polyps, as sludge is mobile and layering, while true polyps are fixed and non-mobile 1, 3
Do not follow stable simple hepatic or renal cysts, as this wastes resources without improving outcomes 4
Minor size fluctuations of 2-3 mm in polyps are part of natural history and should not trigger intervention if future imaging is done 1